Regulation of human cytochrome P450 4F2 expression by sterol regulatory element-binding protein and lovastatin.
about
CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variantCytochrome P450 ω-Hydroxylases in Inflammation and CancerCYP4 enzymes as potential drug targets: focus on enzyme multiplicity, inducers and inhibitors, and therapeutic modulation of 20-hydroxyeicosatetraenoic acid (20-HETE) synthase and fatty acid ω-hydroxylase activitiesGene regulation of CYP4F11 in human keratinocyte HaCaT cells.PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver DiseaseGene activation regresses atherosclerosis, promotes health, and enhances longevity.Fatty acid omega-oxidation as a rescue pathway for fatty acid oxidation disorders in humans.PharmGKB summary: very important pharmacogene information for CYP4F2Genistein, resveratrol, and 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside induce cytochrome P450 4F2 expression through an AMP-activated protein kinase-dependent pathway.Eicosanoids in metabolic syndrome.Human cytochrome p450 family 4 enzymes: function, genetic variation and regulation.Expression of CYP4F2 in human liver and kidney: assessment using targeted peptide antibodies.Current challenges in personalizing warfarin therapy.VEGFA rSNPs, transcriptional factor binding sites and human disease.Role of 20-Hydroxyeicosatetraenoic Acid (20-HETE) in Androgen-Mediated Cell Viability in Prostate Cancer Cells.
P2860
Q24322624-1B021AF8-10D0-4BFB-A647-0B7A4225F690Q26800210-070EBA58-B92E-41C5-90CF-82F7A894B1E3Q28290987-2FC296A1-B3C1-4312-BC0C-0ACDCE5EA0D4Q33574661-9B30679B-64D8-44BC-99E4-20BF98E4AB1AQ33734125-7842E82B-D715-4C74-9FCB-52C2B8326AF6Q34020016-680D843A-CD54-45C7-9A0A-885957D8ED2FQ34025017-940E397F-AE6A-4005-9F7A-096F5936FE3CQ34664072-D00E1350-E08D-4616-9F8A-EDBE8AB23450Q34715847-6F1CED58-3CFD-4598-A35E-1824EEA85ED7Q36911098-17E4DF39-A609-4AF3-A250-FD4C21D45E30Q36929610-7156F8E4-9534-44C8-A720-EA9D4E6D2A80Q37109910-51B3B45C-6563-4B97-BCBB-B7F7FDBB3193Q37960511-6CD494F5-B8A9-4FCA-A681-E05671979340Q43622589-B423ADF3-BE47-49BE-93F3-C9D588C7BBDDQ48238746-5C9176B9-C107-4810-B478-2434152BFF0D
P2860
Regulation of human cytochrome P450 4F2 expression by sterol regulatory element-binding protein and lovastatin.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Regulation of human cytochrome ...... inding protein and lovastatin.
@ast
Regulation of human cytochrome ...... inding protein and lovastatin.
@en
Regulation of human cytochrome ...... inding protein and lovastatin.
@nl
type
label
Regulation of human cytochrome ...... inding protein and lovastatin.
@ast
Regulation of human cytochrome ...... inding protein and lovastatin.
@en
Regulation of human cytochrome ...... inding protein and lovastatin.
@nl
prefLabel
Regulation of human cytochrome ...... inding protein and lovastatin.
@ast
Regulation of human cytochrome ...... inding protein and lovastatin.
@en
Regulation of human cytochrome ...... inding protein and lovastatin.
@nl
P2093
P2860
P356
P1476
Regulation of human cytochrome ...... inding protein and lovastatin.
@en
P2093
Eric F Johnson
Keith J Griffin
Mei-Hui Hsu
Uzen Savas
P2860
P304
P356
10.1074/JBC.M608176200
P407
P577
2006-12-01T00:00:00Z